University of Colorado
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of Colorado
Orchard Therapeutics is on the cusp of the first approval for its ex vivo gene therapy, Libmeldy, for metachromatic leukodystrophy.
Novartis’s siRNA for lowering cholesterol was also among the 10 new medicines that the European Medicines Agency this week said should be approved in the EU.
The sponsors of 11 new treatments should learn this week whether the European Medicines Agency will recommend EU marketing approval for their products.
Among the six new investigational products to make it onto the European Medicines Agency’s priority medicines scheme, five were gene therapies.
- Academic and Research Institutions